Peccatori N, Curto A, Silvestri D, Rebellato S, et al. Measurable Residual Disease-Dependent Unfavorable Outcomes in Pediatric PAX5-Rearranged B-Acute Lymphoblastic Leukemia. Blood 2026 Aug 10:blood.2026033546. doi: 10.1182/blood.2026033546.
PMID: 42574325